Cargando…
The Impact of Levetiracetam and Valproate on Platelet Functions—A Double-Blind, Placebo-Controlled Crossover Study
It is known that valproate inhibits platelet functions; however, the exact mechanisms are not clearly identified. We studied 12 healthy adult volunteers (1 female, 11 male; age range 31.7 ± 7.8 years) before and after valproate 500 mg and compared the results to levetiracetam 1000 mg as a control su...
Autores principales: | Olaizola, Itziar, Brodde, Martin F., Kehrel, Beate E., Evers, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917486/ https://www.ncbi.nlm.nih.gov/pubmed/36769581 http://dx.doi.org/10.3390/jcm12030933 |
Ejemplares similares
-
Plasmin-Induced Activation of Human Platelets Is Modulated by Thrombospondin-1, Bona Fide Misfolded Proteins and Thiol Isomerases
por: Pielsticker, Claudia, et al.
Publicado: (2020) -
Comparison of Levetiracetam and sodium Valproate in migraine prophylaxis: A randomized placebo-controlled study
por: Sadeghian, Homa, et al.
Publicado: (2015) -
An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study
por: Sen, Arjune, et al.
Publicado: (2021) -
Effects of Levetiracetam Compared to Valproate on Cognitive Functions of Patients with Epilepsy
por: El Sabaa, Ramy M, et al.
Publicado: (2020) -
Levetiracetam/sodium valproate: Lack of efficacy: case report
Publicado: (2022)